The Janus Face of Death Receptor Signaling during Tumor Immunoediting.
Ontology highlight
ABSTRACT: Cancer immune surveillance is essential for the inhibition of carcinogenesis. Malignantly transformed cells can be recognized by both the innate and adaptive immune systems through different mechanisms. Immune effector cells induce extrinsic cell death in the identified tumor cells by expressing death ligand cytokines of the tumor necrosis factor ligand family. However, some tumor cells can escape immune elimination and progress. Acquisition of resistance to the death ligand-induced apoptotic pathway can be obtained through cleavage of effector cell expressed death ligands into a poorly active form, mutations or silencing of the death receptors, or overexpression of decoy receptors and pro-survival proteins. Although the immune system is highly effective in the elimination of malignantly t
SUBMITTER: O' Reilly E
PROVIDER: S-EPMC5086583 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
ACCESS DATA